Disclosures
Pushpa Narayanaswami, MBBS, DM, FAAN
| Scientific Advisory Boards | |
| 1. Commercial entity: Alexion pharmaceuticals 2. Commercial entity: Argenx 3. Commercial entity: Momenta | |
| Funding for travel or speaker honoraria | |
| Commercial: Alexion Commercial: UCB pharma | |
| Editorial Boards | |
| 1. Neurology. Level of Evidence Review Team 2012- 2. Muscle and Nerve: Associate editor: October 2016- 3. Journal of clinical neuromuscular disease: Member of Editorial Board 2012- 4. Annals of Neurology: Member, editorial Board 2017- 5. MORE, Mc Master Online Rating of Evidence: Reviewer 2018- | |
| Consultancies | |
| 1. Commercial entity: Momenta Pharmaceuticals 2. Commercial entity: Alexion 3. Commercial entity: Argenx 4. Commercial Entity: UCB pharma | |
| Other activities | |
| Commercial Entity: Blue Cross Blue Shield of MA - Pharmacy and Therapeutics Committee | |
| Research Support, Commercial Entities | |
| 1.Momenta Pharmaceuticals 2. Alexion Pharmaceuticals 3. Ra Pharmaceuticals | |
| Research Support, Government Entities | |
| 1. PCORI, 1609-35953, Co-Primary Investigator, 2017-2021 | |